Journal of Molecular Biology
Volume 228, Issue 4, 20 December 1992, Pages 1193-1205
Journal home page for Journal of Molecular Biology

Article
Nuclear magnetic resonance solution structure of hirudin(1–51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain

https://doi.org/10.1016/0022-2836(92)90325-EGet rights and content

Abstract

The three-dimensional structure of the N-terminal 51-residue domain of recombinant hirudin in aqueous solution was determined by 1H nuclear magnetic resonance (NMR) spectroscopy, and the resulting high-quality solution structure was compared with corresponding structures obtained from studies with the intact, 65-residue polypeptide chain of hirudin. On the basis of 580 distance constraints derived from nuclear Overhauser effects and 109 dihedral angle constraints, a group of 20 conformers representing the solution structure of hirudin(1–51) was computed with the program DIANA and energyminimized with a modified version of the program AMBER. Residues 3 to 30 and 37 to 48 form a well-defined molecular core with two antiparallel β-sheets composed of residues 14 to 16 and 20 to 22, and 27 to 31 and 36 to 40, and three reverse turns at residues 8 to 11 (type II), 17 to 20 (type II′) and 23 to 26 (type II). The average root-mean-square deviation of the individual NMR conformers relative to their mean co-ordinates is 0.38 Å for the backbone atoms and 0.77 Å for all heavy atoms of these residues. Increased structural disorder was found for the N-terminal dipeptide segment, the loop at residues 31 to 36, and the C-terminal tripeptide segment. The solution structure of hirudin(1–51) has the same molecular architecture as the corresponding polypeptide segment in natural hirudin and recombinant desulfatohirudin. It is also closely similar to the crystal structure of the N-terminal 51-residue segment of hirudin in a hirudin-thrombin complex, with root-mean-square deviations of the crystal structure relative to the mean solution structure of 0.61 Å for the backbone atoms and 0.91 Å for all heavy atoms of residues 3 to 30 and 37 to 48. Further coincidence is found for the loop formed by residues 31 to 36, which shows increased structural disorder in all available solution structures of hirudin, and of which residues 32 to 35 are not observable in the electron density map of the thrombin complex. Significant local structural differences between hirudin(1–51) in solution and hirudin in the crystalline thrombin complex were identified mainly for the N-terminal tripeptide segment and residues 17 to 21. These are further analyzed in an accompanying paper.

References (59)

  • F. Markwardt

    Hirudin as an inhibitor of thrombin

    Methods Enzymol.

    (1970)
  • G. Otting

    Zero-quantum suppression in NOESY and experiments with a z filter

    J. Magn. Reson.

    (1990)
  • G. Otting et al.

    Suppression of zero-quantum coherence in NOESY and soft-NOESY

    J. Magn. Reson.

    (1990)
  • M. Rance et al.

    Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filtering

    Biochem. Biophys. Res. Commun.

    (1983)
  • T.J. Richmond

    Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect

    J. Mol. Biol.

    (1984)
  • T.J. Rydel et al.

    Refined structure of the hirudin-thrombin complex

    J. Mol. Biol.

    (1991)
  • M. Scharf et al.

    Primary structures of new ‘Iso-hirudins’

    FEBS Letters

    (1989)
  • T. Szyperski et al.

    Impact of protein-protein contacts on the conformation of hirudin in the X-ray crystal structure of a complex with thrombin studied by comparison with the NMR solution structure of hirudin(1–51)

    J. Mol. Biol.

    (1992)
  • G. Wagner et al.

    Truncated driven nuclear overhauser effect (TOE). A new technique for studies of selective 1H-1H Overhauser effects in the presence of spin diffusion

    J. Magn. Reson.

    (1979)
  • G. Wagner et al.

    Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra, Basic pancreatic trypsin inhibitor

    J. Mol. Biol.

    (1982)
  • G. Wider et al.

    Sequential resonance assignments in protein 1H nuclear magnetic resonance spectra. Glucagon bound to perdeuterated dodecylphosphocholine micelles

    J. Mol. Biol.

    (1982)
  • M.P. Williamson et al.

    Solution conformation of proteinase inhibitor IIa from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry

    J. Mol. Biol.

    (1985)
  • K. Wüthrich et al.

    Sequential resonance assignments as a basis for determination of spatial protein structures by high resolution proton nuclear magnetic resonance

    J. Mol. Biol.

    (1982)
  • K. Wüthrich et al.

    Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance

    J. Mol. Biol.

    (1983)
  • A. Yonath et al.

    Polymers of tripeptides as collagen models. IV. Structure of poly(l-prolyl-glycyl-l-proline)

    J. Mol. Biol.

    (1969)
  • Anil-Kumar et al.

    A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules

    Biochem. Biophys. Res. Commun.

    (1980)
  • Anil-Kumar et al.

    Buildup rates of the nuclear Overhauser effect measured by two-dimensional proton magnetic resonance spectroscopy: implications for studies of protein conformation

    J. Amer. Chem. Soc.

    (1981)
  • M. Billeter et al.

    Restrained energy refinement with two different algorithms and force fields of the structure of the α-amylase inhibitor tendamistat determined by NMR in solution

    Biopolymers

    (1990)
  • W. Bode et al.

    The refined 1.9 Å crystal structure of human α-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment

    EMBO J.

    (1989)
  • Cited by (54)

    • Enzyme inhibitor in regulating beverage processing

      2022, Value-Addition in Beverages through Enzyme Technology
    • Automated prediction of protein association rate constants

      2011, Structure
      Citation Excerpt :

      Hirudin is a potent thrombin inhibitor isolated from the bloodsucking leech Hirudo medicinalis. It consists of 65 residues and has a tadpole-like conformation with a compact N-terminal domain and a highly acidic, disordered C-terminal tail (Szyperski et al., 1992). The N-terminal domain binds to the active site of thrombin, whereas the C-terminal tail binds to a basic exosite, the fibrinogen recognition site (Rydel et al., 1991).

    • The NMR solution structure of recombinant RGD-hirudin

      2007, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      However, its function can be inhibited by hirudin. Structural studies conducted on hirudin in the free [9,17–21] and thrombin-bounded state [10,22] indicated that the C-terminal of hirudin also plays an important role in the interaction with thrombin, such as its long extended conformation interacts with a multitude of residues on the thrombin surface. This cliff-like binding exosite of thrombin is an extension of the active-site-cleft and it is particularly abundant in positively charged side chains of the Phe34 to Leu41 and Lys70 to Glu80 loops of thrombin [23].

    View all citing articles on Scopus
    View full text